EXHIBIT 23.1
Published on August 16, 2023
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of Apollo Medical Holdings, Inc. for the registration of common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts, units, and subscription rights and to the incorporation by reference therein of our reports dated March 1, 2023, except for effects of the restatement discussed in Note 1, as well as the reportable segments disclosures discussed in Note 21, as to which the date is August 9, 2023, with respect to the consolidated financial statements of Apollo Medical Holdings, Inc., and the effectiveness of internal control over financial reporting of Apollo Medical Holdings, Inc., included in its Annual Report (Form 10-K/A) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Los Angeles, California
August 16, 2023